|
Section 500.23
|
Emergency permit control |
|
Section 500.24
|
Anthelmintic drugs for use in animals |
|
Section 500.25
|
Timed-release dosage form drugs |
|
Section 500.26
|
Methylene blue-containing drugs for use in animals |
|
Section 500.27
|
Gentian violet for use in animal feed |
|
Section 500.29
|
Gentian violet for animal drug use |
|
Section 500.30
|
Use of polychlorinated biphenyls (PCB's) in the production, handling, and storage of animal feed |
|
Section 500.45
|
Hexachlorophene in animal drugs |
|
Section 500.46
|
Propylene glycol in or on cat food |
|
Section 500.50
|
Labeling of animal drugs; misbranding |
|
Section 500.51
|
Use of terms such as ``tonic'', ``tone'', ``toner'', or ``conditioner'' in the labeling of preparations intended for use in or |
|
Section 500.52
|
Exemption from certain drug-labeling requirements |
|
Section 500.55
|
Epinephrine injection 1:1,000 in 10-milliliter containers for emergency treatment of anaphylactoid shock in cattle, horses, sheep, |
|
Section 500.65
|
Scope of this subpart |
|
Section 500.80
|
Definitions |
|
Section 500.82
|
Conditions for approval of the sponsored compound |
|
Section 500.84
|
Marker residue and target tissue |
|
Section 500.86
|
Regulatory method |
|
Section 500.88
|
Waiver of requirements |
|
Section 500.90
|
Implementation |
|
Section 500.92
|
N-methyl-2-pyrrolidone |
|
Section 500.1410
|
Principal display panel of package form animal food |